Brief: Simcere Pharmaceutical Says SIM0500 For Injection Granted U.S. FDA Fast Track Designation
09/04/2024 16:08
April 9 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* SIM0500 FOR INJECTION GRANTED U.S. FDA FAST TRACK
DESIGNATION
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660